首页|含铋剂三联疗法对Hp阳性的消化性溃疡患儿血清Gas、TGF-α、hs-CRP水平的影响

含铋剂三联疗法对Hp阳性的消化性溃疡患儿血清Gas、TGF-α、hs-CRP水平的影响

扫码查看
目的 探讨含铋剂三联疗法对幽门螺杆菌(Hp)阳性的消化性溃疡患儿血清胃泌素(Gas)、转化生长因子-α(TGF-α)、高敏C-反应蛋白(hs-CRP)水平的影响。方法 选取嘉兴市第二医院2020年1月至2021年12月收治的96例Hp阳性的小儿消化性溃疡患儿为研究对象,按随机数字表余数分组法分为2组,其中对照组(48例)采用奥美拉唑+克拉霉素+阿莫西林治疗,观察组(48例)采用含铋剂三联疗法(阿莫西林+甲硝唑+枸橼酸铋钾)治疗,治疗10 d后,观察两组临床疗效、临床症状改善时间、Hp转阴率、治疗前后血清指标(Gas、TGF-α、hs-CRP)及不良反应发生情况。结果 观察组总有效率及Hp转阴率显著高于对照组[95。83%(46/48)vs 81。25%(39/48),97。92%(47/48)vs 83。33%(40/48),P<0。05],上腹疼痛、烧心、反酸症状改善时间均显著短于对照组(均P<0。05)。治疗10 d后,两组血清Gas、hs-CRP水平均较治疗前显著下降(均P<0。05),且观察组治疗后低于对照组(均P<0。05);两组TGF-α水平均较治疗前升高(均P<0。05),且观察组治疗后高于对照组(P<0。05)。两组不良反应发生率比较,差异无统计学意义[4。17%(2/48)vs 2。08%(1/48),P>0。05]。结论 含铋剂三联疗法治疗Hp阳性的小儿消化性溃疡疗效更好,可通过改善炎症反应促进溃疡黏膜修复,安全性良好。
The effect of bismuth containing triple therapy on serum Gas,TGF-α,hs-CRP levels in children with Hp positive peptic ulcers
Objective To explore the effect of bismuth containing triple therapy on serum gastrin(Gas),transforming growth factor-α(TGF-α),and high-sensitivity C-reactive protein(hs-CRP)levels in children with Helicobacter pylori(Hp)positive peptic ulcers.Methods A total of 96 children with Hp positive peptic ulcers admitted to the Second Hospital of Jiaxing from January 2020 to December 2021 were selected as the study subjects.They were randomly divided into two groups using the remainder of a random number table.The control group(48 cases)received treatment with omeprazole,clarithromycin,and amoxicillin,while the observation group(48 cases)received treatment with bismuth containing triple therapy(amoxicillin+metronidazole+bismuth potassium citrate).After 10 days of treatment,the clinical efficacy of the two groups was evaluated The improvement time of clinical symptoms,Hp conversion rate,serum indicators(Gas,TGF-α,hs-CRP)before and after treatment,and incidence of adverse reactions were observed.Results The total effective rate and Hp conversion rate of the observation group were significantly higher than those of the control group[95.83%(46/48)vs 81.25%(39/48),97.92%(47/48)vs 83.33%(40/48),P<0.05].The improvement time of upper abdominal pain,heartburn,and acid reflux symptoms was significantly shorter than that of the control group(all P<0.05).After 10 days of treatment,the serum Gas and hs-CRP levels in both groups significantly decreased compared to before treatment(all P<0.05),and the observation group was lower than the control group after treatment(P<0.05);The levels of TGF-α in both groups increased compared to before treatment(all P<0.05),and the observation group was higher than the control group after treatment(P<0.05).There was no statistically significant difference in the incidence of adverse reactions between the two groups[4.17%(2/48)vs 2.08%(1/48),P>0.05].Conclusions The triple therapy with bismuth containing agents has a better therapeutic effect on children with Hp positive peptic ulcers,and can promote ulcer mucosal repair by improving inflammatory response,with good safety.

Peptic ulcerHelicobacter pyloriDrug therapy,combinationInflammation

范宜佳、祝峰、滕懿群

展开 >

嘉兴市第二医院儿科,嘉兴 314000

消化性溃疡 幽门螺杆菌 药物疗法,联合 炎症

浙江省科技计划

2021C03064

2024

中国医师杂志
中华医学会 湖南省医学会

中国医师杂志

CSTPCD
影响因子:0.876
ISSN:1008-1372
年,卷(期):2024.26(3)
  • 24